Comparing the value of data visualization methods for communicating harms in clinical trials
File(s)mxac005.pdf (258.1 KB)
Published version
Author(s)
Type
Journal Article
Abstract
In clinical trials, harms (adverse events) are often reported by simply counting the number of people who experienced each event. Reporting only frequencies ignores other dimensions of the data that are important for stakeholders, including severity, seriousness, rate (recurrence), timing, and groups of related harms. Additionally, application of selection criteria to harms prevents most from being reported. Visualization of data could improve communication of multidimensional data. We replicated and compared the characteristics of six different approaches for visualizing harms-Dot Plot, Stacked Bar Chart, Volcano Plot, Heatmap, Treemap, and Tendril Plot. We considered binary events using individual participant data (IPD) from a randomized trial of gabapentin for neuropathic pain. We assessed their value using a heuristic approach and group of content experts. We produced all figures using R and share the open-source code on GitHub. Most original visualizations propose presenting individual harms (e.g., dizziness, somnolence) alone or alongside higher level (e.g., by body systems) summaries of harms, although they could be applied at either level. Visualizations are able to present different dimensions of all harms observed in trials. Except for the Tendril plot, all other plots do not require IPD. The Dot Plot and Volcano Plot are favoured as visualization approaches to present an overall summary of harms data. Our value assessment found the Dot Plot and Volcano Plot were favoured by content experts. Using visualizations to report harms could improve communication. Trialists can use our provided code to easily implement these approaches.
Date Issued
2022-09-05
Date Acceptance
2022-08-17
Citation
Epidemiologic Reviews, 2022, 44 (1), pp.55-66
ISSN
0193-936X
Publisher
Oxford University Press
Start Page
55
End Page
66
Journal / Book Title
Epidemiologic Reviews
Volume
44
Issue
1
Copyright Statement
© The Author(s) 2022. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
License URL
Identifier
https://www.ncbi.nlm.nih.gov/pubmed/36065832
PII: 6692449
Subjects
Adverse Events
Controlled Clinical Trials
Data Visualization
Drug-Related Side Effects and Adverse Reactions
Harms
Health Communication
Randomized Controlled Trials
Publication Status
Published
Coverage Spatial
United States
Date Publish Online
2022-09-18